SDS Optic won the Innovation radar Prize 2020 for the best innovation created by Women.

SDS Optic has been granted “Women-led Innovation” award at Innovation Radar Prize 2020, a prestigious achievement announced yearly by the European Commission. The  competition recognizes the best European innovation and its founder.

The award has been granted for inPROBE – a photonics-based microprobe for a quick and precise breast cancer diagnostic.

Breast cancer is one of the most common form of cancers. Every year more than 1,7mln women are diagnosed globally, with more than half a million deaths. A clear opportunity and chance for these patients is fast and reliable diagnosis,  that today is fully based on tissue biopsy and the time consuming histopathology testing.

We can change this status quo with the innovation created by Magdalena Staniszewska, PhD DSc, Co-Founder & CSO of SDS Optic Inc. The inPROBE is a disruptive diagnostics device, offering quick and precise targeted tumor markers assessment.

SDS Optic has received almost €4mln European Commission funding from the SME Instrument Horizon2020 program to run clinical trials and certification of the inPROBE.

Magdalena Staniszewska, PhD, DSc

Leading biotechnology scientis with several years of experience at Harvard Medical School in Boston, MA (USA) and Polish Academy of Sciences. A scientist with broad experience in discovering molecular bases of diseases, identifying targets and developing novel therapeutic strategies for diabetic complications, cancer and eye diseases. Co-invented analytical tools and diagnostic markers of pathological neovessels, holds track record of scientific publications and public speaking.

Medical devices

inPROBE – disruptive platform technology with global potential to challenge the paradigm of targeted biology diagnostics and real-time targeted drugs delivery monitoring

Nowadays millions of people die each year from cancer. It’s a medical professionals to save lives of patients worldwide.At the same time the future of cancer therapies is here now, several targeted or gene therapies are gaining trust, but their efficiency is strictly depends on proper and real time targeted tumor biology diagnostics, which doeas not exist yet. That’s why we’ve invented and developed inPROBE, a platform technology which links targeted therapies with targeted diagnostics.Our technology will reduce diagnosis time, increase precision and improve the effects of innovative cancer treatments. It can be used both in cancer diagnostics and therapies monitoring in real time and in a natural state, thus giving medical professionals a previously unavailable fast and efficient tool.

Key benefits

How it works

inPROBEis a nano-size glass probe placed in vivo inside a very thin biopsy needle, connected to a detecting device and with innovative components on a probe tip. Thanks to it’s thickness it is safer, much less stressful and much less painful.Fast and precise cancer diagnosis combined with modern therapies can help to SAVE UP TO 30% of people diagnosed with cancer by 2030.The high sensitivity of inProbe enables it into examine even single cells. It also allows to close access to the tumor without the need to get into the tumor as today, which can lead to malignant cancer.

All the data gathered during the procedure is transferred via fiber optics into the multi- purpose detecting device. The data is then calculated using specific algorithms and presented to the oncologist as a diagnostic result – a numerical measurement with exact level of tested components (e.g. HER2 cancer biomarker).

During cancer therapies inProbe will be able to measure the level of active ingredients (e.g. Trastuzumab) in cancer tumor cells, thus supporting & improving the efficiency of modern targeted cancer therapies and patients’ well-being.

Testimonials

SDS-MicroProbe can be a groundbreaking solution to overcome problems in current technology and enable analysis of biological processes inside the single cell in their natural state. As an expert in hematology, I am convinced that such solution would find several applications in research as well as in future cell therapies in the cancer area.

Hematologist/Oncologist M.D. PhD
with several years of scientific experience at NIH
Bethesda, MD, USA

There is an unmet need to study biological processes within individual cells residing in their native niche. The SDS-MicroProbe addresses this shortcoming; it is a new approach in analyzing key intracellular parameters that indicate the functionality of a cell. The SDS-MicroProbe has the potential to substantially advance our ability to assess the status of living cells and thereby improve our ability to diagnose various diseases and evaluate the efficiency of interventions.

Professor, PhD of Harvard Medical School
Boston, MA, USA

Brochure

If you want to know more about our project, you can download the newest brochure here or visit our website www.inprobe.com

Optoelectronics

SDS OPTIC specializes in modeling and designing high-quality package components, such as ferrules, housings, and other devices with flat and conical surface areas. We employ highly accurate assembling procedures that allow us to compose hermetic patch cords, pigtails, connectors and windows. It is essential to know how the assembly phases influence the properties of optoelectronic components to avoid damage caused by thermal stresses. Specifically, it is crucial to apply proper stress distribution to all parts of the component at every manufacturing stages. As a result, we model the ideal shape and dimensions of all types of packages to achieve a mild stress allocation.

Our high-precision developing processes of optoelectronics assembly ensures that our customers eliminate positioning problems during assembly steps. SDS OPTIC strongly propagates techniques, which allow to eliminate the old metallization methods, previously leading to a 25% decrease in fiber strength, the possibility of organic contamination, low manufacturing and a high rate of rejection.

SDS OPTIC is capable of designing and fabricating custom-specified fiber optics Pig-Tails and Connectors. Cost-effective assembling procedures allow us gather precision products with a high level of hermeticity. The assembling method is free of time-consuming and costly pre-metallization processing. The Climatic Validation Report reveals the quality enforced during assembly. On request, test reports may accompany any shipment or consignment.

A finite element thermal stress analysis is employed to achieve the proper geometry and dimension of package components. Utilizing this process, mild stress distribution is obtained among all areas of completed assemblies – as can be seen in the symmetric cross-section.

Biotech r&d

SDS Optic, based in Lublin, Poland, is a cutting-edge biotech company specializing in connecting vast medical knowledge with technical skills to create medical devices that can revolutionize healthcare worldwide.

Our strategy is to discover, develop, produce and commercialize on global scale unique diagnostics and monitoring tools working in real-time and in natural state, which support and save lives.

We concentrate on helping the healthcare with faster, less painful diagnostics and supporting targeted, effective treatment procedures. We develop and create different diagnostics & monitoring solutions, incl. the ones used in cancer diagnostics and cancer treatment. Our team consists of renown experts in biology, optoelectronics, physics, medicine, advanced technologies, chemistry and related sciences.

SDS Optic is innovative integrated multidisciplinary biotechnology R&D partner for the pharmaceutical and biotechnology industries with office in Lublin, Poland and research associates both in Poland and in the United States.

The company offers targeted diagnostics discovery support at every stage of the early discovery phase up to the preclinical research phase.
Currently SDS Optic employs over 10 scientists, majority with PhD degree and extensive experience in several areas of life sciences, offering the following types of projects:

  • Contract Chemistry services
  • Molecular Biology services
  • Targeted innovative multidisciplinary in vivo diagnostics & monitoring solutions development
  • Comparative studies of biosimilar products
  • Integrated multiple key-steps pre-clinical discovery projects
  • Early stage in vivo & in vitro diagnostic technologies scale-up and commercialization